Tyrosine Kinase Inhibitors: all 10,469 studies that test it
Page 50 of 105. Open to participants first (1,907), then studies with results posted, then the rest; newest registration first within each.
- OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell CancerCompletedNCT00076310Phase 2Results posted
- AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast CancerCompletedNCT00076024Phase 1/2Results posted
- Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine CancerCompletedNCT00075400Phase 2Results posted
- Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast CancerCompletedNCT00075270Phase 3Results posted
- A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)CompletedNCT00075218Phase 3Results posted
- Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced CancersCompletedNCT00074308Phase 1/2Results posted
- Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast CancerCompletedNCT00073528Phase 3Results posted
- Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell CancerCompletedNCT00073307Phase 3Results posted
- A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung CancerTerminatedNCT00073008Phase 2Results posted
- Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic SyndromesCompletedNCT00072475Phase 2Results posted
- AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)CompletedNCT00071006Phase 2Results posted
- Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous LeukemiaActive, not recruitingNCT00070499Phase 2Results posted
- A Phase II Trial of STI571 in the Treatment of Metastatic Gastric CancerCompletedNCT00068380Phase 2Results posted
- S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath TumorCompletedNCT00068367Phase 2Results posted
- Sorafenib in Treating Patients With Refractory Non-Small Cell Lung CancerCompletedNCT00064350Phase 2Results posted
- Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung CancerTerminatedNCT00063258Phase 2Results posted
- Erlotinib Plus Carboplatin and Paclitaxel in Ovarian CarcinomaCompletedNCT00059787Phase 2Results posted
- ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the SkinCompletedNCT00054691Phase 2Results posted
- Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast CancerCompletedNCT00054275Phase 2Results posted
- Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast CancerCompletedNCT00054132Phase 2Results posted
- Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by SurgeryCompletedNCT00049543Phase 3Results posted
- Imatinib Mesylate in Treating Patients With Recurrent Brain TumorCompletedNCT00049127Phase 1/2Results posted
- Imatinib Mesylate in Treating Patients With Recurrent MeningiomaCompletedNCT00045734Phase 2Results posted
- Erlotinib in Treating Patients With Advanced Kidney CancerCompletedNCT00045487Phase 2Results posted
- Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive MeningiomaCompletedNCT00045110Phase 1/2Results posted
- A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular CarcinomaCompletedNCT00044512Phase 2Results posted
- Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed GliomasCompletedNCT00042991Phase 1/2Results posted
- Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00039377Phase 2Results posted
- Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib MesylateCompletedNCT00038675Not applicableResults posted
- Therapy of Early Chronic Phase CML With Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-CTerminatedNCT00038649Phase 2Results posted
- Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic LeukemiaCompletedNCT00038610Phase 2Results posted
- Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or NilotinibCompletedNCT00036738Phase 2Results posted
- Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu OverexpressionCompletedNCT00033514Phase 1/2Results posted
- Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal TumorCompletedNCT00028002Phase 2Results posted
- Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous LeukemiaTerminatedNCT00022490Phase 2Results posted
- Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent GliomaTerminatedNCT00021229Phase 1/2Results posted
- Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous LeukemiaTerminatedNCT00015847Phase 2Results posted
- Benmelstobart Plus Anlotinib Versus Sunitinib as First-Line Treatment for Advanced Non-Clear Cell Renal Cell CarcinomaActive, not recruitingNCT07881900Phase 3
- An Open-label DDI Study to Investigate the Effect of Rilzabrutinib on P-gp, BCRP, OATP1B1 and OATP1B3 InhibitionActive, not recruitingNCT07855250Phase 1
- Baricitinib for Central Centrifugal Cicatricial Alopecia in Adults of African DescentCompletedNCT07843732Phase 2
- A Clinical Trial to Evaluate [14C]-MK-4208/[14C]-TERN-701 in Healthy Adult Male Participants (MK-4208-002/TERN701-1016)CompletedNCT07839000Phase 1
- A Clinical Trial to Evaluate MK-4208/Embibatinib in Healthy Adult Participants (MK-4208-001/Embibatinib-1014)CompletedNCT07838987Phase 1
- Tofacitinib in the Treatment of IgG4 Related DiseasesCompletedNCT07827469Not applicable
- Lucitanib (AL3810) in Patients With Advanced Thymic Carcinoma After ChemotherapyCompletedNCT07824505Phase 2
- Topical Delgocitinib for Facial VitiligoActive, not recruitingNCT07820098Phase 2
- Efficacy of Asciminib in Chronic Phase CML Patients With T315I MutationsActive, not recruitingNCT07789574Phase 2
- An Interventional Study of Upadacitinib Extended-Release Tablets in Patients With Refractory UveitisActive, not recruitingNCT07773623Phase 4
- Phase 1 Study in Healthy Adults to See How Sevabertinib Changes Metformin Levels in the BodyCompletedNCT07753252Phase 1
- A 24-Week Real-World Study of Upadacitinib in Moderate-to-Severe Hidradenitis SuppurativaActive, not recruitingNCT07727889Phase 2
- QT Interval/Corrected QT Interval （QT/QTc） Clinical Study to Evaluate the Cardiac Safety of TQ05105 Tablets in Healthy ParticipantsActive, not recruitingNCT07708272Phase 1
- Second-Line Sacituzumab Tirumotecan Plus Anlotinib for Advanced Driver Gene-Negative Non-Squamous NSCLCActive, not recruitingNCT07703228Phase 2
- The Study on Effects of CYP3A and P-glycoprotein Inhibitor Itraconazole and CYP Enzyme Inducer Rifampin of HMPL-453 Tartrate TabletsCompletedNCT07697157Phase 1
- A Study in Healthy Men to Test How Bosentan Influences the Amount of Zongertinib in the BloodCompletedNCT07649941Phase 1
- Does Cediranib Prevent Bowel Perforation in Platinum-resistant Ovarian CancerCompletedNCT07648745Phase 2
- Assessment of Interleukin-15 and Interferon Gamma in Alopecia Areata Before and After Baricitinib.CompletedNCT07645430Not applicable
- Study on [14C]HMPL-453（FGFR Inhibitor） in Healthy Chinese Adult Male SubjectsCompletedNCT07644442Phase 1
- A Study on the Effect of Food and Proton Pump Inhibitor on the Pharmacokinetics of HMPL-760 CapsulesCompletedNCT07643272Phase 1
- Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract CancerActive, not recruitingNCT07635290Phase 2
- Ivarmacitinib for Refractory Behcet's SyndromeWithdrawnNCT07634848Phase 2
- Study to Evaluate the Effect of Rabeprazole Sodium Enteric-coated Tablets on the Pharmacokinetics of TQ05105 TabletsActive, not recruitingNCT07608666Phase 1
- Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy SubjectsCompletedNCT07588646Phase 1
- A Study to Evaluate Dermal Open-Flow Microperfusion and Plasma Pharmacokinetic Study of Multiple Doses of Oral Povorcitinib or Topical Ruxolitinib Cream in Healthy Adult ParticipantsCompletedNCT07588139Phase 1
- Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)CompletedNCT07539090Phase 1
- Efficacy and Safety Comparison Between PD-1 Inhibitor Combined With Lenvatinib or With Regorafenib For UHCC After Failure of First-line TreatmentCompletedNCT07537985Not applicable
- Treatment of Orelabrutinib+Hi-CVP Regimen for Previously Untreated MZLActive, not recruitingNCT07480863Phase 2
- Efficacy of Tofacitinib on Skin Thickening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With MethotrexateCompletedNCT07472166Phase 4
- A Mass Balance Study of DZD8586 in Healthy Male Participants (TAI-SHAN15)CompletedNCT07454863Phase 1
- COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DMEActive, not recruitingNCT07449936Phase 3
- CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DMEActive, not recruitingNCT07449923Phase 3
- A Phase 1 Study of the Safety and How the Body Processes ABBV-722 and Upadacitinib After Multiple Oral Doses in Healthy Adult ParticipantsCompletedNCT07425899Phase 1
- A Study of Elenestinib in Healthy Adult Female ParticipantsCompletedNCT07388511Phase 1
- Pacritinib With Aza for Upfront Myelodysplastic SyndromeWithdrawnNCT07387354Phase 1/2
- An Investigational Study to Evaluate the Cardiac Safety Assessment (TQTc Study) of ESK-001CompletedNCT07378579Phase 1
- Fluorizoparib Plus Apatinib Versus Chemotherapy in HRD-positive, HER2-negative Advanced Breast CancerActive, not recruitingNCT07371910Phase 3
- Comparative Effectiveness of Ruxolitinib Monotherapy Versus Its Combination With Tacrolimus and Corticosteroids in the Management of Vitiligo: A Randomized Controlled TrialCompletedNCT07368673Phase 4
- Study of Food Effect on Pharmacokinetics of HMPL-523 Acetate TabletsCompletedNCT07348133Phase 1
- Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With MyelofibrosisActive, not recruitingNCT07340138Phase 1
- Pharmacokinetics and Bioequivalence Study of HMPL-523 Acetate Tablets in HumansCompletedNCT07331194Phase 1
- A Clinical Trial of Mass Balance of [14C] TQ05105 in Healthy Chinese SubjectsCompletedNCT07293390Phase 1
- Neoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutation.Active, not recruitingNCT07274761Phase 2
- A Study of the Effect of Diltiazem on the Plasma Levels of Nemtabrutinib (MK-1026-022)CompletedNCT07232589Phase 1
- A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.Active, not recruitingNCT07228390Phase 2
- Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult ParticipantsCompletedNCT07223671Phase 1
- A Trial of Regorafenib Plus Lorigerlimab in Patients With Locally Recurrent or Regrowing pMMR/MSS Localized Rectal CancerWithdrawnNCT07223567Phase 2
- RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on ImmunotherapyWithdrawnNCT07218692Phase 2
- Rilzabrutinib for the Adult Participants With Chronic ITP Who Have Completed Phase 3 Study in JapanActive, not recruitingNCT07216079Phase 3
- A Study to Evaluate the Relative Bioavailability of Pimicotinib Capsules Containing Free Base in Different Proportions in Healthy SubjectsCompletedNCT07210996Phase 1
- A Study to Investigate the Pharmacokinetics of Tirabrutinib in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Healthy ParticipantsCompletedNCT07198087Phase 1
- A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLCActive, not recruitingNCT07183189Phase 3
- Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)SuspendedNCT07181382Phase 3
- A Study to Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Adults With Treatment-Naive Waldenström MacroglobulinemiaActive, not recruitingNCT07169331Phase 4
- Phase II Study to Assess the Efficacy of ASLAN001 Plus Capecitabine in CNS Metastases for HER2+ Breast CancerTerminatedNCT07166367Phase 2
- Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood CancersActive, not recruitingNCT07162181Phase 2
- Evaluate the Effect of Vimseltinib on Organic Cation Transporter 2 (OCT2)CompletedNCT07158411Phase 1
- Evaluate the Effect of Vimseltinib on the Pharmacokinetics of a BCRP and OATP1B1 SubstrateCompletedNCT07158398Phase 1
- Improving Physical Ability and Cellular Senescence Elimination in HIVCompletedNCT07144293Phase 2
- A Bioavailability Study of Nilotinib in Healthy, Adult, Human Subjects Under Fasted Conditions.CompletedNCT07138378Phase 1
- A Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-limited Metastatic Colorectal CancerWithdrawnNCT07137390Phase 1/2
- A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant ChemotherapyActive, not recruitingNCT07136077Phase 2
- A Study to Evaluate the the Bioequivalence of Two Different Pimicotinib Capsules in Healthy SubjectsCompletedNCT07126249Phase 1